FIGURE 2.

Schematic representation of (a) The formation of nanomicelle by the self‐assembly of amphiphilic molecule, with subsequent loading of drugs, thereby forming drug encapsulated nanomicelle; (b) The entry of the nanomicelle with subsequent release of drugs, targeting the mitochondria, nucleus and cell membrane bound receptor, thereby acting as potential therapeutic in treating cancer; (c) The entry of the nanomicelle in the inner part of the eye and releasing the loaded drug in the retinal pigment epithelium crossing the scleral aqueous channel thereby being highly efficient for the treatment of occular diseases; (d) Nanomicelle penetrating the hair follicles and releasing the drugs in the skin lipids, bypassing the skin barrier to treat skin diseases